GLMD Galmed Pharmaceuticals Ltd.

-

Galmed Pharmaceuticals Reported Earnings

Wednesday, July 8, 2026 · 12:00 AM ET

Galmed Pharmaceuticals (GLMD) reported a loss of $0.29 per share on revenue of $0.00 million for the . .

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing therapies for liver diseases and gallstones. Galmed Pharmaceuticals Ltd. is based in Tel Aviv, Israel.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.29)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth53.2 %
Reported Revenue
Revenue Estimate
Revenue Surprise
Revenue Growth